2.5. Prognostic Value of HSPB2 mRNA Expression in Patients with Breast Adenocarcinoma, Stratified According to Molecular Subtype, Anatomic Stage, or Prognostic Stage. This evidence concerns the gene HSPB2 and breast adenocarcinoma.